Artificial intelligence and machine learning could support drug development for hepatitis A virus internal ribosomal entry sites
Artificial Intelligence in Gastroenterology · 2021
DOI: 10.35712/aig.v2.i1.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Artificial Intelligence in Gastroenterology, 2021. Verfasst von Tatsuo Kanda und 3 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 71 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kanda, T., Sasaki, R., Masuzaki, R., & Moriyama, M. (2021). Artificial intelligence and machine learning could support drug development for hepatitis A virus internal ribosomal entry sites. Artificial Intelligence in Gastroenterology. https://doi.org/10.35712/aig.v2.i1.1
Vancouver
Kanda T, Sasaki R, Masuzaki R, Moriyama M. Artificial intelligence and machine learning could support drug development for hepatitis A virus internal ribosomal entry sites. Artificial Intelligence in Gastroenterology. 2021. doi:10.35712/aig.v2.i1.1
BibTeX
@article{Kanda2021,
author = {Kanda, Tatsuo and Sasaki, Reina and Masuzaki, Ryota and Moriyama, Mitsuhiko},
title = {Artificial intelligence and machine learning could support drug development for hepatitis A virus internal ribosomal entry sites},
journal = {Artificial Intelligence in Gastroenterology},
year = {2021},
doi = {10.35712/aig.v2.i1.1}
}
EUVIMED